310 related articles for article (PubMed ID: 18556571)
1. Murine models of hyperhomocysteinemia and their vascular phenotypes.
Dayal S; Lentz SR
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1596-605. PubMed ID: 18556571
[TBL] [Abstract][Full Text] [Related]
2. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
3. The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia.
DiBello PM; Dayal S; Kaveti S; Zhang D; Kinter M; Lentz SR; Jacobsen DW
Mol Cell Proteomics; 2010 Mar; 9(3):471-85. PubMed ID: 20008833
[TBL] [Abstract][Full Text] [Related]
4. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
[TBL] [Abstract][Full Text] [Related]
5. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
Lentz SR; Erger RA; Dayal S; Maeda N; Malinow MR; Heistad DD; Faraci FM
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H970-5. PubMed ID: 10993757
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of thrombosis in hyperhomocysteinemia.
Lentz SR
Curr Opin Hematol; 1998 Sep; 5(5):343-9. PubMed ID: 9776214
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia in polycystic ovary syndrome: decreased betaine-homocysteine methyltransferase and cystathionine β-synthase-mediated homocysteine metabolism.
Li D; Liu HX; Fang YY; Huo JN; Wu QJ; Wang TR; Zhou YM; Wang XX; Ma XX
Reprod Biomed Online; 2018 Aug; 37(2):234-241. PubMed ID: 29804940
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine and atherothrombosis: diagnosis and treatment.
Handy DE; Loscalzo J
Curr Atheroscler Rep; 2003 Jul; 5(4):276-83. PubMed ID: 12793968
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of homocysteine-induced atherothrombosis.
Lentz SR
J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia and cardiovascular disease in animal model.
Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y
Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979
[TBL] [Abstract][Full Text] [Related]
12. Effects of betaine in a murine model of mild cystathionine-beta-synthase deficiency.
Schwahn BC; Wendel U; Lussier-Cacan S; Mar MH; Zeisel SH; Leclerc D; Castro C; Garrow TA; Rozen R
Metabolism; 2004 May; 53(5):594-9. PubMed ID: 15131763
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.
Dayal S; Chauhan AK; Jensen M; Leo L; Lynch CM; Faraci FM; Kruger WD; Lentz SR
Blood; 2012 Mar; 119(13):3176-83. PubMed ID: 22186991
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary supplementation with folate on choline deficiency-induced hyperhomocysteinemia in rats.
Liu Y; Liu YQ; Morita T; Mori M; Sugiyama K
J Nutr Sci Vitaminol (Tokyo); 2012; 58(1):20-8. PubMed ID: 23007063
[TBL] [Abstract][Full Text] [Related]
16. Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.
Dayal S; Blokhin IO; Erger RA; Jensen M; Arning E; Stevens JW; Bottiglieri T; Faraci FM; Lentz SR
PLoS One; 2014; 9(9):e107734. PubMed ID: 25226386
[TBL] [Abstract][Full Text] [Related]
17. Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemia.
Tawfik A; Al-Shabrawey M; Roon P; Sonne S; Covar JA; Matragoon S; Ganapathy PS; Atherton SS; El-Remessy A; Ganapathy V; Smith SB
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):939-49. PubMed ID: 23307965
[TBL] [Abstract][Full Text] [Related]
18. Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice.
Wilson KM; McCaw RB; Leo L; Arning E; Lhoták S; Bottiglieri T; Austin RC; Lentz SR
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):233-40. PubMed ID: 17082485
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
20. Dietary Egg Protein Prevents Hyperhomocysteinemia via Upregulation of Hepatic Betaine-Homocysteine S-Methyltransferase Activity in Folate-Restricted Rats.
Saande CJ; Pritchard SK; Worrall DM; Snavely SE; Nass CA; Neuman JC; Luchtel RA; Dobiszewski S; Miller JW; Vailati-Riboni M; Loor JJ; Schalinske KL
J Nutr; 2019 Aug; 149(8):1369-1376. PubMed ID: 31111947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
